Examol Corporation

Startup
Summarized by Halo AI

Examol is a cloud-native software company providing a computational drug discovery platform that integrates molecular databases, AI tools, and scalable workflows to streamline drug design and development for the pharmaceutical industry.

Founded & HQ
Pittsburgh, Pennsylvania, USA
Company size
1-10 employees
Activity highlights
Released cloud-native drug discovery software and biophysics simulation solutions to optimize drug residence times and in vivo efficacy.

Examol Corporation is a biotechnology research company that develops cloud-native, open-source computational drug discovery workflow tools. The company’s platform integrates a centralized, AI-ready molecule database with modern user interfaces and APIs to streamline drug design and optimization. By providing accessible tools for computational chemistry and physics-based simulations, Examol enables researchers to run complex workflows at scale in the cloud without managing infrastructure.

These tools are designed to help pharmaceutical and biotechnology companies improve data reliability, automate intricate processes, and accelerate the development of life-changing therapeutics. By focusing on computational solutions, Examol addresses key challenges in small molecule drug discovery, allowing organizations to leverage advanced AI and computational methods to solve complex problems and design better patient treatments more efficiently.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

SL
Samuel Lotz
Chief Technology Officer
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.